Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death (Q43142736)

14 November 2017

title

Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death (English)

1 reference

14 November 2017

1 reference

1 reference

14 November 2017

1 reference

14 November 2017

Karin A Thursky

0 references

Sharon C-A Chen

1 reference

14 November 2017

Deborah Marriott

1 reference

14 November 2017

C Orla Morrissey

1 reference

14 November 2017

Quoc Nguyen

1 reference

14 November 2017

David H Ellis

series ordinal

1 reference

14 November 2017

Australian Candidemia Study, Australasian Society for Infectious Diseases

series ordinal

1 reference

14 November 2017

language of work or name

English

0 references

publication date

4 March 2010

1 reference

Journal of Antimicrobial Chemotherapy

14 November 2017

1 reference

inferred from page(s)

published in

1 reference

14 November 2017

1 reference

14 November 2017

1 reference

14 November 2017

page(s)

1042-1051

1 reference

Candidaemia in Europe: epidemiology and resistance

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

Epidemiology of invasive candidiasis: a persistent public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

Association of fluconazole pharmacodynamics with mortality in patients with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

Active surveillance for candidemia, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

Recommendations for the treatment of established fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ053

21 January 2018

Identifiers

DOI

10.1093/JAC/DKQ053

1 reference

14 November 2017

1 reference